Status:
TERMINATED
In-exsufflator Cough Assist Device in Patients With Symptomatic Bronchiectasis
Lead Sponsor:
University of Massachusetts, Worcester
Conditions:
Bronchiectasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is a randomized, controlled trial examining the effectiveness of the mechanical cough-assist device (in-exsufflator) in promoting the clearance of retained airway secretions in patients wit...
Detailed Description
Bronchiectasis is characterized by airway dilatation with the potential to cause devastating illness, including repeated respiratory infections requiring antibiotics, disabling productive, mucopurulen...
Eligibility Criteria
Inclusion
- Chest CT scan confirmation of bronchiectasis
- At least two exacerbations in the preceding 12 months requiring antibiotics
Exclusion
- Cystic fibrosis
- Bullous emphysema
- History of spontaneous pneumothorax
- History of massive hemoptysis: greater than 200 cc in a 24 hour period
- Lung resection surgery in the past 6 months
- Use of the mechanical cough in-exsufflator in the prior 3 months
- Inability to speak and read English
- Inability to demonstrate proper use of the cough-assist or flutter device
- Unable to provide informed consent
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00452114
Start Date
April 1 2004
End Date
May 1 2008
Last Update
September 18 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UMass Memorial Medical Center, Universty Campus
Worcester, Massachusetts, United States, 01605
2
St. Vincent Medical Center
Worcester, Massachusetts, United States, 01608